SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-019211
Filing Date
2017-11-14
Accepted
2017-11-14 08:31:20
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20170930_10q.htm 10-Q 615665
2 EXHIBIT 31.1 ex_99826.htm EX-31.1 13444
3 EXHIBIT 31.2 ex_99827.htm EX-31.2 13376
4 EXHIBIT 32.1 ex_99828.htm EX-32.1 5224
5 EXHIBIT 32.2 ex_99829.htm EX-32.2 5519
  Complete submission text file 0001437749-17-019211.txt   3839621

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snbp-20170930.xml EX-101.INS 713690
7 XBRL TAXONOMY EXTENSION SCHEMA snbp-20170930.xsd EX-101.SCH 47722
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20170930_cal.xml EX-101.CAL 27870
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20170930_def.xml EX-101.DEF 320952
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20170930_lab.xml EX-101.LAB 264942
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20170930_pre.xml EX-101.PRE 337804
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 171198479
SIC: 2834 Pharmaceutical Preparations